EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The Systemic Immune-Inflammation Index Predicts Portal Vein Tumor Thrombosis and Informs a Clinical Nomogram in HBV-Related Hepatocellular Carcinoma

Runci Jiang, Shuqin Cheng, Lu Jiang, Yuexi Yu, Menghua Lin, Yiping Zhang, Jingyu Shen, Guliziba Abudumijiti, Boyuan Xiao, Haoyang Pang, Fengmei Wang iD

Clinical and Applied Thrombosis/Hemostasis · 2026-01 · 32

DOI: 10.1177/10760296261433671 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Applied Thrombosis/Hemostasis, online erschienen am 11.03.2026. Verfasst von Runci Jiang und 10 weiteren Autor:innen. Beteiligte Einrichtung: First Central Hospital of Tianjin Medical University, Tianjin, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Nomograms, Portal Vein. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Incubation Fund of Tianjin First Central Hospital, Tianjin Natural Science Foundation Project, Tianjin Municipal Education Commission Scientific Research Program Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study aims to investigate the potential association between the incidence of portal vein tumor thrombosis (PVTT) and a panel of inflammatory indices—namely the systemic immune-inflammatory index (SII), platelet-to-lymphocyte ratio (PLR), and neutrophil-to-lymphocyte ratio (NLR)—in patients with HBV-related hepatocellular carcinoma (HCC).

Methods

Covariates were identified through univariate and multivariate logistic regression analyses alongside the variance inflation factor (VIF). The associations of inflammatory biomarkers were evaluated using subgroup analyses, multivariate logistic regression, and restricted cubic spline (RCS) models. A nomogram was developed based on the selected variables, and calibration curves were plotted to assess the predictive accuracy of the model. Receiver operating characteristic (ROC) curves were generated, and the area under the curve (AUC) was calculated to evaluate the diagnostic performance of the model.

Results

In this study of 504 HBV-related HCC patients, PVTT was identified in 22.02% of cases. Multivariate analysis confirmed SII and PLR as independent risk factors for PVTT, with the third quartile of SII and PLR associated with 109.7% and 122.6% increased risk, respectively. A nonlinear dose-response relationship for SII was identified with an inflection point at 467.5. A nomogram incorporating SII and five clinical variables demonstrated good predictive accuracy (AUC = 0.760) and high specificity (84%), supporting its utility for clinical risk stratification.

Conclusions

The SII was identified as an independent risk factor for PVTT in patients with HBV-related HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsNomogramsPortal VeinVenous ThrombosisInflammationHepatitis B virusHepatitis BHumansFemaleMaleMiddle AgedAdult

Stichwörter der Autor:innen

hepatitis B virus-related hepatocellular carcinomaneutrophil-to-lymphocyte ratioplatelet-to-lymphocyte ratioportal vein tumor thrombosissystemic immune-inflammatory index

Autor:innen und Institutionen

  • First Central Hospital of Tianjin Medical University, Tianjin, China.
  • Tianjin Medical University, Tianjin, China.
  • Tianjin Key Laboratory of Molecular Diagnosis and Treatment of Liver Cancer, Tianjin First Central Hospital, Tianjin, China.
  • Department of Gastroenterology and Hepatology, Tianjin First Central Hospital, Tianjin, China.

ORCID-Profile: Fengmei Wang

Förderung

  • Incubation Fund of Tianjin First Central Hospital
  • Tianjin Natural Science Foundation Project
  • Tianjin Municipal Education Commission Scientific Research Program Project

Zitieren

APA

Jiang, R., Cheng, S., Jiang, L., Yu, Y., Lin, M., Zhang, Y., Shen, J., Abudumijiti, G., Xiao, B., Pang, H., & Wang, F. (2026). The Systemic Immune-Inflammation Index Predicts Portal Vein Tumor Thrombosis and Informs a Clinical Nomogram in HBV-Related Hepatocellular Carcinoma. Clinical and Applied Thrombosis/Hemostasis, 32. https://doi.org/10.1177/10760296261433671

Vancouver

Jiang R, Cheng S, Jiang L, Yu Y, Lin M, Zhang Y, et al. The Systemic Immune-Inflammation Index Predicts Portal Vein Tumor Thrombosis and Informs a Clinical Nomogram in HBV-Related Hepatocellular Carcinoma. Clinical and Applied Thrombosis/Hemostasis. 2026;32. doi:10.1177/10760296261433671

BibTeX
@article{Jiang2026,
  author = {Jiang, Runci and Cheng, Shuqin and Jiang, Lu and Yu, Yuexi and Lin, Menghua and Zhang, Yiping and Shen, Jingyu and Abudumijiti, Guliziba and Xiao, Boyuan and Pang, Haoyang and Wang, Fengmei},
  title = {The Systemic Immune-Inflammation Index Predicts Portal Vein Tumor Thrombosis and Informs a Clinical Nomogram in HBV-Related Hepatocellular Carcinoma},
  journal = {Clinical and Applied Thrombosis/Hemostasis},
  year = {2026},
  volume = {32},
  doi = {10.1177/10760296261433671}
}
Kostenlos starten →